Paid Advertisement
Please join us for a free CME dinner symposium at AHA. The treatment of pulmonary arterial hypertension (PAH) is evolving. With the emergence of disease-modifying therapies (DMTs), it is essential that healthcare providers understand their mechanisms of action and are aware of the safety and efficacy data of recently published clinical trials. In this satellite symposium, HCPs will learn how to integrate new treatment strategies using both existing and emerging therapeutic entities. You don’t want to miss this opportunity to enhance your ability to customize a risk-based approach for comprehensive management of your patients with PAH.
Click here to register: www.ReachMD.com/AHA24